MoneyWorks4Me

The sales is pegged at Rs. 559.63 millions for the September 2022 quarter. The mentioned figure indicates a decline of about -69.54% as against Rs. 1837.12 millions during the year-ago period.A radical decline of -84.83% was reported in the net profit of the company for the quarter ended September 2022 to Rs. 90.48  millions from Rs. 596.59 millions.A decline of 163.26 millions was observed in the OP in the quarter ended September 2022 from 835.37 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 559.63 1837.12 -69.54 1261.82 3039.03 -58.48 4561.32 2615.03 74.43
Other Income 7.52 1.17 542.74 11.29 10.72 5.32 35.12 15.88 121.16
PBIDT 163.26 835.37 -80.46 347.26 1320.29 -73.70 1752.36 308.47 468.08
Interest 11.83 7.11 66.39 24.02 13.90 72.81 29.17 26.12 11.68
PBDT 151.43 828.26 -81.72 323.24 1306.39 -75.26 1723.19 282.35 510.30
Depreciation 38.27 26.45 44.69 69.58 47.06 47.85 106.44 64.36 65.38
PBT 113.16 801.81 -85.89 253.66 1259.33 -79.86 1616.75 217.99 641.66
TAX 22.68 205.22 -88.95 57.68 319.22 -81.93 416.29 63.84 552.08
Deferred Tax -3.09 2.23 -238.57 -3.09 2.23 -238.57 2.75 1.62 69.75
PAT 90.48 596.59 -84.83 195.98 940.11 -79.15 1200.46 154.15 678.76
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 29.17 45.47 -35.84 27.52 43.44 -36.65 38.42 11.80 225.68
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..